Question 1

Does Bridgewater Associates own TXG stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Bridgewater Associates holds 13,375 shares of TXG (10x Genomics), worth $512,798.

Question 2

How many shares of TXG does Bridgewater Associates own?

Accepted Answer

As of its Q2 2026 13F, Bridgewater Associates holds 13,375 shares of TXG (10x Genomics).

Question 3

What is Bridgewater Associates' TXG position worth?

Accepted Answer

As of its Q2 2026 13F, Bridgewater Associates' TXG position is worth $512,798.

Question 4

Is Bridgewater Associates buying or selling TXG?

Accepted Answer

In Q2 2026, Bridgewater Associates reduced its TXG position by 21,726 shares (-61.9%).

Question 5

When did Bridgewater Associates first buy TXG?

Accepted Answer

Bridgewater Associates first reported TXG in its Q3 2021 13F and has listed it in 7 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Decreased	13,375	-61.9%	$512,798	0.0%	$38.34	0
2026-Q1	Decreased	35,101	-80.3%	$745,194	0.0%	$21.23	0
2025-Q4	New	177,734	-	$2.9M	0.0%	$16.31	36
2023-Q1	Exited	0	-100.0%	$0	0.0%	$52.05	0
2022-Q4	New	13,044	-	$475,323	0.0%	$36.44	33
2022-Q3	Exited	0	-100.0%	$0	0.0%	$29.93	0
2022-Q2	Increased	8,676	+40.3%	$393,000	0.0%	$46.20	32
2022-Q1	New	6,182	-	$470,000	0.0%	$74.74	33
2021-Q4	Exited	0	-100.0%	$0	0.0%	$150.88	0
2021-Q3	New	1,988	-	$289,000	0.0%	$145.94	32